MedPage Today) — CHICAGO — Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF) hospitalization for this technology…
Read More
Policybanaoo.com No1 Insurance company in India